About us
People
Pipeline
News
Investors
Contact
ARMOR Phase 3 Study

Board Committees

Investors Home
Press Releases
Events & Presentations
SEC Filings
Stock Info
Corporate Governance
Get Alerts
Investor Contact

Overview

Investors Home
Press Releases
Events & Presentations
SEC Filings
Stock Info
Corporate Governance
Get Alerts
Investor Contact

Nominating Committee

Description of Nominating Committee

Chair

Mr. Chaim Hurvitz

© Galmed Pharmaceuticals | All Rights Reserved.

Term of Use
Privacy Policy
Privacy Notice for California Residents
Privacy Rights Policy
Data Subjects Request Form
Study Subjects Disclaimer

Branding & Website by